TMCnet News
Stock to Watch: Zalicus Up 6.9% (ZLCS)Mar 07, 2013 (SmarTrend(R) Spotlight via COMTEX) -- Zalicus (NASDAQ:ZLCS) is one of today's best performing penny stocks, up 6.9% to $0.70 on 1.5x average daily volume. Zalicus has traded 980,000 shares thus far today, vs. average volume of 656,000 shares per day. The stock has outperformed the Dow (6.9% to the Dow's 0.3%) and outperformed the S&P 500 (6.9% to the S&P's 0.2%) during today's trading. There is potential upside of 187.7% for shares of Zalicus based on a current price of $0.70 and an average consensus analyst price target of $2.00. Zalicus shares should first meet resistance at the 50-day moving average (MA) of $0.70 and find additional resistance at the 200-day MA of $0.87. Zalicus Inc is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. The Company's drug pipeline includes an arthritis formula in phase 2 development. In the past 52 weeks, Zalicus share prices have been bracketed by a low of $0.38 and a high of $3.21 and are now at $0.70, 84% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.2% while the 200-day MA has slid 0.3%. SmarTrend is tracking the current trend status for Zalicus and will alert subscribers who have ZLCS in their portfolio or watchlist when shares have changed trend direction. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |